HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.

AbstractPURPOSE:
Patients with ovarian clear cell adenocarcinoma generally have a poor response to combination chemotherapy and have overall poorer prognosis than patients with other histologic types of ovarian cancer. Genetic changes in this group of cancer have not been thoroughly explored. Identification of these changes may provide us new therapeutic targets to treat this disease.
EXPERIMENTAL DESIGN:
Genomic and expression array analyses were applied on 30 clear cell ovarian cancer cases and 19 serous cases using a 10,816-element cDNA microarray platform. Further validation and clinical correlation studies were done on differentially expressed genes that are related to chemoresistance.
RESULTS:
Based on array analyses, 12 genes showed a significant increase in DNA and mRNA copy number and 5 genes showed a significant decrease in DNA and RNA copy number in clear cell tumors compared with those in the serous type. One of the genes was ABCF2, which belongs to the ATP-binding cassette gene superfamily and has been shown to amplify in other tumor types. Validation studies were done using real-time quantitative PCR and immunohistochemistry. The results showed significantly higher ABCF2 DNA and mRNA copy number and protein levels in clear cell cases compared with those in serous cases. Furthermore, in 20 clear cell cases with chemo-response data available, ABCF2 cytoplasmic staining was significantly higher in nonresponders than that in the responders (60.0% versus 28.5%; P = 0.0002).
CONCLUSIONS:
These data suggest that ABCF2 protein may be a prognostic marker for ovarian clear cell ovarian adenocarcinoma.
AuthorsHiroshi Tsuda, Yoichi M Ito, Yasuo Ohashi, Kwong-Kwok Wong, Yasunori Hashiguchi, William R Welch, Ross S Berkowitz, Michael J Birrer, Samuel C Mok
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 11 Issue 19 Pt 1 Pg. 6880-8 (Oct 01 2005) ISSN: 1078-0432 [Print] United States
PMID16203778 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ABCF2 protein, human
  • ATP-Binding Cassette Transporters
  • Biomarkers, Tumor
  • DNA, Complementary
  • Oligonucleotides
  • DNA
Topics
  • ATP-Binding Cassette Transporters (biosynthesis, genetics)
  • Adenocarcinoma, Clear Cell (metabolism)
  • Adult
  • Aged
  • Biomarkers, Tumor
  • Blotting, Western
  • Cell Line
  • Cell Line, Tumor
  • Cytoplasm (metabolism)
  • DNA (metabolism)
  • DNA, Complementary (metabolism)
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis (methods)
  • Oligonucleotides (genetics)
  • Ovarian Neoplasms (metabolism)
  • Prognosis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: